Contraindicated (1)pentobarbital will lessen the level or outcome of lumefantrine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with strong CYP3A4 inducers may lead to reduced serum concentrations and lack of antimalarial efficacypentobarbital will reduce the level or result of rabeprazole by affecting